
Senior Director – Biostats
Posted 6 days ago

Posted 6 days ago
This is a fully remote position, open to applicants in United States.
• Act as the primary statistician for GondolaBio’s ASO and siRNA initiatives.
• Take charge of the statistical strategy from initial human studies through proof-of-concept and pivotal trials.
• Create and justify fit-for-purpose statistical analysis plans tailored for small sample sizes, placebo and open-label designs, as well as high inter-patient variability.
• Oversee Bayesian go/no-go criteria, probability-of-success assessments, and assurance calculations for portfolio and stage-gate decisions.
• Direct pivotal designs, confirmatory-evidence strategies, integrated summaries, NDA/BLA/MAA statistical sections, information-request responses, advisory committee preparation, and labeling claims.
• Perform statistical due diligence for in-licensing and acquisition opportunities.
• Implement rare-disease trial designs such as delayed-start, crossover, n-of-1, master protocols, randomized withdrawal, and seamless Phase 1/2/3 designs.
• Develop prospective natural-history protocols, establish registry partnerships, and set regulatory-grade external-control data standards.
• Collaborate with clinical teams to identify credible and regulatorily acceptable endpoints.
• Lead the development of disease-progression models to select endpoints, enhance populations, and project long-term benefits.
• Partner with Pharmacometrics and Clinical Pharmacology on MIDD initiatives.
• Integrate external controls and real-world data through target-trial emulation, propensity scores, covariate balancing, quantitative bias and sensitivity analyses, Bayesian inference, and dynamic borrowing.
• Utilize ML-based prognostic covariates for covariate adjustments.
• Identify and address risks related to variability, missing data, and limited statistical power.
• Prepare statistical sections for INDs, FDA/EMA meeting documents, scientific advice documents, endpoint qualification opinions, pediatric extrapolation, and PIP/iPSP strategies.
• Assist in pre-IND, EoP2, and pre-NDA/BLA meetings and respond to inquiries from regulatory agencies.
• Build and lead biostatistics, statistical programming, and data management teams using a hybrid approach of in-house and FSP/FSO sourcing.
• Select and manage vendors that support clinical, translational, and nonclinical analytics and deliverables.
• Collaborate with Clinical Development, Clinical Pharmacology, Pharmacometrics, Regulatory, Clinical Operations, CROs, and vendors.
• Incorporate statistical considerations into protocols, CRF design, data management, and study execution.
• Represent the Statistics function in cross-functional program-team meetings.
• Work with nonclinical, translational, and clinical teams on PD biomarker, target-engagement, and patient-stratification analysis plans.
• Ph.D. in Biostatistics, Statistics, or a closely related discipline.
• Over 10 years of experience in the pharmaceutical or biotech industry.
• Direct experience in early-phase and late-phase rare disease development.
• Proficiency in designing and analyzing clinical and neurological endpoints with high variability.
• Extensive knowledge of rare-disease statistical challenges, such as small sample sizes, open-label designs, natural-history controls, and high inter-patient variability.
• Strong hands-on skills with SAS and/or R.
• Capability to independently program and review analysis datasets and outputs.
• Experience in authoring and defending SAPs, study reports, and regulatory-facing statistical documents.
• Comfort in operating within lean, fast-paced biotech environments while maintaining autonomy and accountability.
• Familiarity with innovative endpoints, multi-domain and composite endpoints, PRO/ClinRO, digital health technology endpoints, and psychometric validation in pediatric or rare-disease populations is preferred.
• Experience with AI/ML and data science is a plus.
• Background in nonclinical, PK/PD, and pharmacometrics data programming and management is advantageous.
• A patient-first, ethical, scientifically rigorous, entrepreneurial, collaborative, and execution-focused mindset.
• Patient Days.
• Culture driven by company values.
• Decentralized model that minimizes bureaucracy and empowers decision-making.
• Ownership of program vision and individual career paths.
• Collaborative, fast-paced, and data-driven work environment.
• Access to learning and development resources.
• Competitive market compensation and benefits package.
• Performance bonuses.
• Equity options.
• Comprehensive health and welfare programs.
• Retirement plans.
• Flexible PTO policy.
• Opportunities for rapid career advancement for high performers.
• Potential to engage in multiple GondolaBio Pharma programs across various therapeutic areas.
Network Connex
Abbott
ACLU
Dexterra Group
Get handpicked remote jobs straight to your inbox weekly.